Hello and welcome to the Lancashire Holdings Limited first quarter 2026 earnings call. Throughout the call, all participants will be in a listen-only mode. Afterwards, there will be a question-and-answer session. The speakers today will be Alex Maloney, Group Chief Executive Officer, Natalie Kershaw, Group Chief Financial Officer, and Paul Gregory, Group Chief Underwriting Officer. I will now hand the call over to Alex.
Thank you, operator. Good morning, everyone. We will follow our usual process this morning. I'll keep it brief and give you my thoughts on the quarter. I'll then hand over to Paul for underwriting summaries, then Natalie for the finance part, then we will take your questions. I want to start by saying that it's been another excellent quarter for Lancashire, where we affirm our guidance for a high teens ROE for the 2026 year. Amidst elevated geopolitical tensions, our business continues to perform strongly, reflecting our prudent strategy. To remind you, we've set out to continue to grow ahead of rate and deliver more sustainable returns for our investors across the cycle. Our track record of delivery supports this with three consecutive years above 20% ROEs and on average, returning 100% of earnings to shareholders.
That's exactly what we're still doing. Firstly, adjusting for reinstatement premiums of last year, our premiums grew ahead of rate again. As we said at the last conference call, the market is getting more competitive, but is still a profitable one. In that context, our excellent underwriting team worked hard to ensure we retained the business we wanted to retain and grew where appropriate. At the same time, we pulled back where appropriate, reducing our retrocession book again, as we flagged at our last conference call. The market has remained competitive, but our proven disciplined management of the underwriting cycle continues to serve us well. Second, whilst there were no big sticker industry loss events in the quarter, the overall claims environment for the industry remains active.
Our own loss experience has been benign, but this environment makes it all the more important to navigate this stage of the cycle with care. Turning to investments, our team navigated a tough market of their own. In light of the heightened uncertainty and volatility, our resilient investment portfolio delivered what it's designed to do in the quarter. Finally, our focus remains firmly on delivering sustainable returns across the cycle, supported by active capital management. Disciplined underwriting and a conservative investment portfolio and a strong balance sheet all support our goals. To that end, our ROE guidance for this year remains in the high teens. I'll now hand over to Paul to take you through some of the details of our underwriting activities.
Thanks, Alex. During the quarter, our market has progressed in line with expectation. We set out these expectations 8 weeks ago, and to summarize, these were as follows: a softening but not soft market with rate reductions at a portfolio level in the high single digits. Rate and adequacy remaining healthy in the majority of classes. Top line to remain broadly stable. Our net cap footprint to be marginally lower year-on-year, and the continued build-out of Lancashire U.S. I'm pleased to report our performance and expectations remain in line with all of these. As you can see, our portfolio RPI is at 93% for Q1, and excluding the impact of reinstatement premiums, our top line remains stable. Underlying this, we see a variance between the reinsurance and insurance portfolios. Reinsurance premiums are less than Q1 last year.
As Alex has mentioned, the primary driver of this was the absence of reinstatement premiums this year, given there were no major catastrophe losses in the quarter, unlike Q1 last year. The only part of the reinsurance portfolio that we've actively reduced was our previously signaled reduction of our inward retrocession portfolio. As we explained last quarter, this is a decision based purely on prudent cycle management, allowing us to better manage our earnings volatility and net cap footprint as we move through the cycle. Offsetting the dynamics in reinsurance was the growth within our insurance portfolio. This growth primarily comes from two areas of the business. The continued and anticipated build-out of the Lancashire U.S. franchise. Growth in Marine and Energy portfolio due to a combination of timing, new business, and organic growth with existing clients.
Given Q1 performance and current market conditions, we're happy to reiterate our guidance of broadly stable top line for the year. Whilst the market has very much performed in line with our expectations, there has obviously been a large degree of political and economic volatility as a result of the war in the Middle East. As previously explained, a number of our specialty lines of business have exposure to the region and the peril of war. Our position from an exposure point of view is very manageable, and we consider ourselves underweight the region. Given this underweight position, it does provide the opportunity for us to underwrite new business, which is coming to the market as demand for war coverage increases.
As you would expect from us, we are doing this in a measured and thoughtful way in order to manage our exposure, but also maximize any opportunities where we feel the balance of risk and reward is appropriate. As we look ahead to the remainder of the year, our focus remains on making sensible underwriting decisions to manage the underwriting cycle, while at the same time, continuing to invest in the business for the long term. We are actively looking to hire good underwriters to strengthen the Lancashire underwriting franchise. We are proactively hiring in niche areas that will incrementally benefit the bottom line through the cycle. Recently adding a new underwriter and product line to our marine team and continuing to build out our bench strength in the maturing Lancashire U.S. platform.
We believe that good underwriters that understand the cycle and know when to be bold and when to be patient will add value and further develop the Lancashire franchise over the longer term. I'll now pass over to Natalie.
Thanks, Paul. Hello, everyone. The first quarter was relatively straightforward from a financial perspective. We continue to see the benefit of business growth over the last few years in our own premium and insurance revenue, which increased by 2.1% compared to the first quarter of 2025. The loss environment was relatively benign, with no major losses of note in the quarter. Likewise, the more attritional part of our book, which consumes little capital, performed in line with expectations. During the quarter, we finalized our year-end regulatory returns with a final BSCR ratio of 254%, slightly ahead of our estimate at the year-end results. This reflects normal refinements made during the finalization of what is by nature a complex modeling process. Now turning to investments. Market volatility, including high yields and wider credit spreads, impacted portfolio valuations during the quarter.
However, total investment returns were positive at 0.3%, with investment income more than offsetting the unrealized losses. Our private investment funds also delivered strong returns. Since inception, the primary objectives for our investment portfolio have been capital preservation and liquidity, and we continue to position that portfolio to limit downside risk in the event of market shocks. Those objectives remain unchanged and are particularly important in today's volatile markets. Looking ahead, we will maintain a short, high credit quality portfolio with appropriate diversification to optimize risk-adjusted returns. The combination of earnings resilience, strong capital, and a conservative investment stance leaves us well-positioned for the remainder of 2026. With that, I'll now hand back to Alex to conclude.
Thank you, Natalie. To conclude, I just want to leave you with three key points for Lancashire at this stage of the cycle. Disciplined growth continues despite a more competitive market. We continue to deliver a resilient performance amidst an active risk environment. Sustainable returns remain the core focus for us, supported by strong capital management, which is why we are affirming our high teens ROE guidance for this year. With that, we'll hand over to the operator for questions.
Thank you. Your first question is from Shanti Kang from Bank of America Merrill Lynch. Your line is now open.
Hi, afternoon. Thanks for taking my question. You guys reiterated the high teens ROE today, which is good, and that was despite the lower top line. I was just wondering if you could help us bridge what structurally supports that ROE as pricing continues to soften. Should we look to you guys looking at the product mix using reinsurance or perhaps investments? How should we think about that into the second half of this year? The second question is just on the RPI. The RPI at 93 suggests a clear softening. I'm just curious to know where you're seeing a bit more pressure today in specific lines within insurance and any sublines in reinsurance as well. Thank you.
I think, Shanti, that, you know, we're a quarter into the year. You know, from our view, we're very much in line with our expectations. We're very much in line with the guidance that we gave you. There's no, you know, there's no real surprises here. Obviously, when we gave you that guidance, we were, you know, trying to predict what the RPI would be this year, trying to predict what the product mix would be this year, and obviously the benefit of reinsurance that we're now purchasing. I think all in all, you know, it is only Q1. I think we're very happy where we are. As you can see from our release, you know, our underwriting portfolio continues to adjust to the market we're in.
You know, that's what, that's what good underwriters do. Clearly, you know, we're gonna manage the cycle. That's what we do at Lancashire. I think we think we're completely in line with where we should be. There's no surprises here. Generally, we've had a good quarter.
Shanti, I think on the second question was on RPI, I think that as we said last quarter, our view was across the overall portfolio, the RPI would be in the high single digits. Obviously, underneath that, there are some products that are higher, seeing higher RPIs than that, as in, you know, more softening. There are others that, to be honest, we are still seeing small rate increases in some small pockets. Generally casualty is broadly stable. As I said in my script, we're kind of happy with the guidance that we gave last quarter, and everything we're seeing thus far doesn't lead us to change any of that. You know, I think high single digits across the overall portfolio remains valid.
The next question is from Vash Gosalia from Goldman Sachs. Your line is now open.
Hi. Thank you for taking my questions. I have two, potentially three. One is again, just following up on the RPI question. Here, could you just help us understand how should we think of the seven points reduction or whatever the reduction of high single-digit in rates, how does that translate into combined ratio for potentially next year? It would be interesting to just understand what levers do you have in the middle so that it does not translate for a 1 is to 1. Second question was maybe a little bit of clarity on something you've mentioned in the past about your casualty reserves. Obviously, you've said you would consider releasing some after five years of underwriting the business.
Are you able to give us a sense of how much reserve or basically the dollar amount of reserves you are holding for the casualty line so that we can get a sense of what's to be released? Third question, potentially a bit more qualitative. How far are we from a soft cycle? Appreciate you seeing the cycle softening, but in your view, what does a soft cycle look like?
Hi, Vash. I'll take the first question. Yeah. The things you need to consider when it comes to the levers are, you know, obviously you see the RPI and what's happening generally to rates. The bit that's more difficult for you to see is, and we've said this before, the one benefit of a softening market is we're obviously a buyer of reinsurance. That obviously helps manage our combined ratios 'cause both the cost of that reinsurance generally reduces. But probably more importantly is the breadth of product that we can buy, which helps us manage our earnings volatility and ultimately our combined ratios. That's the main lever that you need to consider.
obviously, as we move through the year and have a better visibility on the market in 2027, we can give you some more commentary around that. That's the, that's the main thing for you, for you to consider.
Hi, Vash. It's Natalie. I'll take your second question on the casualty reserving. Obviously, as I think you'll be aware, we don't give the dollar amounts of reserves by portfolio mix. Obviously, we do give you the amount of our risk margin, which we disclosed at the year-end, which is effectively the total amount of prudence that we have in the reserves. We did start writing casualty around five years ago now, but that was the first year, so we have very small amount of excess reserves from that first year. We're not necessarily considering releasing anything at the moment. I think if you're thinking about what to model for us, I wouldn't be assuming any casualty releases in the near term. Hopefully that's helpful.
Vash, your question about a soft market. You know, we are obsessed with the underwriting cycle. You know, we're firm believers that that's just the way this industry works. I think you can just, you know. I suppose an easier way to think about it is with the guidance that we've given for the year, we very much do not think that means we're in a soft market. Clearly, the market is more competitive, but we still think there's some really good opportunities in the product lines that we write. I definitely don't think anyone actually in the industry would say we're currently in a soft market, but clearly it's a softening market.
That's very helpful. Thank you.
Your next question is from Kamran Hossain from JPMorgan. Your line is now open.
Hey, good afternoon. First question from me is just on the claims experience. You said kind of, you know, benign for yourself in the quarter. I think on one of the conference calls earlier this week, the CEO of a large company said that political violence claims could be a lot more than kind of the amount of premium in the market. Are you just kinda not in the market or is this just better risk selection? Just intrigued kind of why some of that hasn't maybe shown up for yourselves. The second question is on the reduction inwards retro, property retro. Is there much of a combined ratio impact from that? 'Cause I would assume it's pretty low combined ratio, therefore it might have an impact.
Just in intrigue, I understand kind of, you know, ROE is the primary metric as it should be. And the third question on kind of business growth, or kind of how the business is gonna develop over the remainder of the year. I know you've got the kind of the stable headline number for the year as guidance. Clearly reinsurance in Q1, you know, was impacted by the reinstatements, but you won't have that in Q2. I assume there's less impact from retro. Is there anything to suggest that insurance won't be quite as healthy in the remainder of the year as it was in Q1? Thank you.
Okay, Kam. I'll start on point one and then Paul will be a bit more specific about Lancashire. Yes, we have seen that comment about the Middle East. We would agree with that. We do think that the losses that we think are gonna come through the system may exceed the premium for the PV market. You would expect that to come through the, you know, the course of this year, and that will probably affect some of the specialty reinsurance placements. The majority of those are done at the first of January. Yes, we definitely agree with that. You would expect in any class of business where you've got
Premium, you know, claims exceeding premiums, there should be some upwards movements in that class of business. Obviously the continued situation in the Middle East, the prolonged situation, we believe, you know, people are gonna have to re-underwrite those exposures on a more sensible basis. Yes, we do agree with that comment. We think it will come through the system this year, and we do believe the claims exceed the premiums. Paul will just give you a bit more, you know, detail. Go ahead.
Hi, Kam. I think that as I said in my script, we're generally underweight the region and that definitely applies to the kind of political violence product line, that it's an ongoing event. It can change. We do have exposure, as I said, it's definitely underweight. Maybe that explains our experience thus far. That we, again, as I, as I said in the opening remarks, there is currently opportunity, I think being in a position where we're underweight allows us to selectively look at those opportunities, obviously in a very measured way. There is definitely increased demand coming to the market clearly at a very different price point to what we've seen before the war.
We will, you know, be cautiously selective, but we are open for business and we will underwrite those risks and have underwritten more risks since the war began. Moving on to your second question on inwards retrocession. To be honest, I think you've answered it for yourself. Our focus always is on ROE. Look, we grew that retro portfolio when market conditions were really strong. They're not as strong as they were, and for us it's a very capital consumptive line of business. You're right, it does tend to run, kind of depending on the loss year obviously, but would generally be at the lower end of combined ratios. For us, that's not the focus.
The reason for reducing, and we did reduce last year, you'll recall, and, you know, we've been quite open about the fact we would reduce again. This 1 is primarily around how capital consumptive it is, but also the earnings volatility that it can bring 'cause it's a product that's very difficult to reinsure. They're all the reasons. Yes, it runs at a lower combined ratio, but it's very capital intensive. For us, it seems at this part of the cycle, the most sensible thing to do. You're also right that the vast majority of that premium impact is in Q1 'cause the vast majority of the retro portfolio is written at the 1st of January. There is a little bit in Q2, but the vast majority of that impact has been felt.
Then I think the third question was on overall growth for the rest of the year. As I've just said there, you've seen the impact, the vast majority of impact from retro come through the reinsurance lines. Obviously you've seen the. Well, when we talk about growth, we don't really think about reinstatement premiums 'cause we're talking about underlying growth. Yes, you've seen the impact of that in Q1. Very pleased with kind of insurance growth in Q1. Some of that's coming from, you know, areas we flagged eight weeks ago, which is the continued maturity of Lancashire U.S. We continue that. We would expect that to continue through the course of the year. Then for Marine and Energy, it was also a very good Q1.
Some of that is timing, favorable timing with products, sorry, policies renewing into Q1, but it's also in energy, the kind of Energy Liability line that, one, we are growing in Lancashire U.S. Two, is still seeing a relatively good rating environment, and we had the opportunity to increase with some core clients through Q1. Everything said, as you've heard us say, we are sticking to our kind of stable top line guidance for the balance of the year.
That's it. Thanks so much for all the detail, Paul. Sorry for the three questions.
Your next question is from Joseph Theuns from Autonomous Research. Your line is now open.
Good morning to you guys there. Thank you for taking my questions. The first question I had was just a follow-up actually to one of your answers previously about, you know, the cost and availability of reinsurance. You know, does that mean you're reducing the level of retained business, you know, that we can expect this year? Then the second question is just in terms of, you know, casualty book. You know, as casualty, the casualty class remains one of the areas that is still best in terms of rate adequacy. Are you still looking to grow this line of business? Are you happy with kind of the size and, you know, of where the portfolio is today? Thanks for taking my questions again.
Okay, thanks, Joe. On your first question around reinsurance, if you look at us through the cycle, we as a proportion of like our inwards premiums in softer markets, we tend to spend a bigger % on reinsurance, and then harder markets, that % comes down. We're probably at the stage now where if you look at it from that metric perspective, it's going to be, you know, broadly stable versus last year, but perhaps marginally higher, because we are kind of as Alex said, in a softening part of the cycle. I think directionally that's how you need to think about it. On casualty. I think we've said this before, but we're pretty happy with the size of our casualty book in terms of how it sits overall in the Group's portfolio.
Look, there are always opportunities to grow with core clients, and if they're there, we're happy to do it. There'll obviously be other times when maybe deals don't make sense. I think if you, if you want to think about it, I wouldn't see any fundamental changes to the size of our casualty book during the course of this year.
Thanks for your responses.
Thank you. Once again, should you wish to ask a question, you may press star one. Your next question is from Will Hardcastle from UBS. Your line is now open.
Hey, everyone. Hope you're well. Will Hardcastle, UBS. First one is just thinking about that insurance segment premium growth year-on-year. Is it possible to try and sort of just get in rough broad terms, how much of that is new teams and how much is perhaps the opportunistic war-related energy or marine, or is it other energy marine business that's grown? I'm trying to sort of get a feel for that underlying book growth, if that ever makes sense, for Lancashire. Then just thinking about that, it sounds like one of the cuts on the reinsurance book or reductions was on that inward retro. Clearly, that's capital consumptive. I know there's a hell of a lot of the year still to come, and you're not there trying to tell us what pricing will do post the cat season.
I guess just thinking about the incremental news flow we've had quarter-on-quarter and that reduction in inward retro, is it a fair point just to suggest that there's a higher chance of a higher payout ratio year-on-year in that sense, if that makes sense? Thank you.
Okay. Well, I'll take the first question. I think the growth in insurance. First of all, to clarify, the growth that we've seen in Marine and Energy in Q1, that isn't related to any great extent to additional premiums coming from the war. As I've said, we are open for business and happy to underwrite more risk, so we could potentially see the benefit of that as we move through the course of the year. Absolutely. The other areas are effectively younger teams maturing, and that's generally in our Lancashire U.S. platform where, you know, those teams are still building to maturity, and that's where we're seeing growth. That doesn't mean there's not areas of growth elsewhere.
We are still seeing clients on the insurance side bring in kind of more demand to market, nothing specific that I would call out. As I said in my script, we're still hiring. You know, we are looking to add new underwriters to our business. You know, we've recently hired a new underwriter in Marine in London for a niche. They won't arrive until later in the year, the impact is not really going to be seen this year. We are still very focused on that, we believe in the current M&A environment, there will be opportunities for us to add more talented underwriters to the group.
Great. Hi, Will. It's Natalie. Thanks for the capital question. Similar to the question before, you've almost answered your own question. As you know, we try and remain disciplined and flexible with capital as the year develops, we look at various capital deployment options as the year goes on. One of the things obviously we keep an eye on is the cat season, as you mentioned. It would be our usual timing when considering any capital returns would be towards the end of the year, dependent on what happened during the course of the year.
Thank you.
Your next question is from Darius Satkauskas from KBW. Your line is now open.
Oh, yeah. Thanks for taking my questions. The first question is just on the BSCR. Your estimate at the time of the full year results was 240, I believe, and I think today it's 254. It's 14 points difference. It's not tiny. Could you disclose what's driving this in terms of is it the numerator? Is it denominator because of changing growth assumptions or just, you know, a combination of many moving parts? Another question is just on the reinsurance. Did I understand you correctly that you are thinking of slightly increasing the total reinsurance dollar spend? You know, not only you are banking the reinsurance sort of cheaper reinsurance prices, you're buying more of it to sort of offset what's happening in your primary divisions.
Is that correct? Thank you.
Hi, Darius. It's Natalie. I'll take the question on the BSCR. I think it's probably helpful if I explain the process around that. The BSCR is a year-end 2025 metric. What happens is those regulatory solvency returns are not due to the regulator until the end of May. While we're going through the year-end process at the beginning of the year, we're really focusing more on things like the annual report, et cetera, and these regulatory returns tend to come after that. It's a quite a complex involved modeling process from an actuarial perspective. We try to give a reasonable estimate in March, but then you've obviously got another six weeks of work happening after that. In this case, it's really around the technical provisions that are used in the BSCR.
What happens is, you basically remove our IFRS 17 loss reserve, and you're replacing them with technical provisions to come up with a true economic balance sheet. Those technical provisions can move around a little bit during the process. On your question about what was driving it, the technical provisions actually impact the numerator and the denominator because they impact the charges you get, the capital charges. They also impact your denominator by increasing the amount of capital that's available. It's not really reflective of anything that's going on in the business this year. It's more reflective of the process and the modeling assumptions around that. Hopefully that makes a little bit sense.
On your second question, Darius, I think, like, as I just answered on a previous question, I think, you know, dollar-wise, it's going to be broadly similar year-on-year, but at the margin, if it's going one way, it might go slightly up. That's completely in line with how we manage the cycle and how you'd have seen us by reinsurance through cycle in the past. Not anything material for 2026 for you to think about.
Helpful. Thank you.
Your next question is from Abid Hussain from Panmure Liberum. Your line is now open.
Hello, everyone. I think I've just got one question left. It's just around the link between the pricing and ROE. I'm just wondering if you're able to provide some sort of guidance on, say, a 5 percentage point move or on rates, and then how that feeds through to ROE. I know that's incredibly difficult thing to do, but just some sense, sort of given, you know, the various levers that you do have on whether it's retro, asset leverage, reserve releases, you know, current year margins. There's clearly things that you are doing and can do to achieve decent ROEs. There's clearly not a one-to-one translation between pricing and ROE. I'm just trying to get a sense of how you think about that.
Hi, Abid. It's Natalie. Thanks for the question. I'll take that one on how we come up with the ROE guidance. Obviously, the guidance factors in a lot of different scenarios that could happen in all areas of the business, all areas of the balance sheet. Our priority when we give the guidance is to give something we're confident in delivering across a range of scenarios. That would include changes in RPI, changes in investment returns, changes in the cat and large losses and loss assumptions, et cetera. We are, as we've said, we're reaffirming guidance, and we're quite confident to reaffirm that at the moment.
Okay.
Your next question is from Shanti Kang from Bank of America Merrill Lynch. Your line is now open.
Hi. Thanks for the follow-up. I was just thinking after the renewal period and the first quarter for this year, is there anything that sort of surprised you about the conditions that you've gone through to make you think differently going into mid-year renewals? I know you've got the RPI dropping high single digits year-on-year. Is your baseline view in that softening will still be orderly rather than a dislocation, for example? Don't know if you've got any thoughts on that. Thanks.
Look, I think, thus far, and even if you look at the 1/4 renewals, everything is very much playing out as we anticipated. I think as we said earlier, look, there are, there are some lines that are more competitive than others, definitely. Kind of at a portfolio level, we're happy with the, with the guidance that we've given. There's nothing thus far that has led us to change that. We are in a softening market, that is clear. My anticipation is that as we move through the rest of the year, it will remain very similar to what we're seeing now. Look, no surprises thus far. We were anticipating a softening market.
In some lines, we're anticipating some, you know, quite, you know, more competitive pressure than in others, and that's happening. As I say, no massive surprises thus far.
Yeah. I think, like, in certain product lines, you know, the PV question was an obvious one earlier. Clearly, you know, we believe losses exceed premium in that class. You could probably say the same about the Downstream Energy sector. You know, look, you know, there's been a fair bit of loss activity there. Aviation continues to be difficult. You know, there are there's underwriting needed in certain classes of business, but I think the general trend, you know, we are in the softening phase. You know, we, you know, we don't change that or any acceleration or deceleration into wind season. Obviously, we'll see what the wind season brings.
Cool. Thank you.
Your next question is from Will Hardcastle from UBS. Your line is now open.
Thanks for the follow-up. Just one industry loss estimate that's been increasing appears to be the Baltimore Bridge loss. If you could just give us an update, whether it be what industry or loss you're assuming, I'm sure it's bottom-up. If that's developed since your initial loss pick, that'd be helpful. Thank you.
Hi, Will. I'll take this one. look, as you know, we try not to talk about specific claims too much. appreciate obviously it's a major event and in the press.
You know, you know how we reserve, and you're right, we do it bottom up, and we try to be as prudent as we possibly can. We definitely don't, on any loss, take just the initial loss pick we, we may be given or presented with. We come up with our own view of where we think the ultimate loss may land. Obviously, you know, we review these assumptions if we get updated information, et cetera, and you've seen us do that on other losses and, you know, that could have either been positive, or negative, and we, and we revise accordingly. Obviously, in the aggregate, our track record is pretty good.
I think look what you can take from today's re-ascertain of ROE guidance for the year is that if there would be any change here, it's not gonna be material enough to impact that guidance.
Super helpful. Thanks, guys.
Thank you. Your next question is from Joseph Theuns from Autonomous. Your line is now open.
Hi. Thanks for allowing a follow-up question. Apologies if you sort of touched on this already, but can you just give any more sort of rationale behind the reason behind merging the two Lloyd's syndicates? I'm just wondering if there's any sort of capital benefits to doing this. Thanks.
I think. Look, I think we mentioned this before. You know, we were fortunate enough to buy out the names that we had on Syndicate 2010 last year. You know, that was a, that was a good deal for Lancashire, but it was also, you know, a good deal for the names that we had. By merging the syndicates, we definitely get some synergies in cost. You know, there's lots of things we won't have to do twice. I think that's a benefit. That will also be good timing for us. You know, the 2027 year, you know, again, that will help us save some expenses in 2027, not materially. I think on the capital side, you know, we will be more capital efficient at Lloyd's and just running one syndicate just simplifies our business.
You know, one thing we're trying to do all the time is simplify our business, trying to be as cost-efficient as we can, which all aids us managing the cycle. Yeah, we should be able to get that done for 2027 and have one simple syndicate in Lloyd's.
Thanks for that. Super helpful.
Thank you. There are no further questions at this time. I will now hand the call back over to Alex Maloney for the closing remarks.
Okay. Thank you for your questions today. We'll close the call there.
Thank you. This now concludes our conference call. Thank you all for attending. You may now disconnect your line.